Long-Term Effect of Overnight Orthokeratology on Axial Length Elongation in Childhood Myopia: A 5-Year Follow-Up Study

Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls. There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion...

Full description

Saved in:
Bibliographic Details
Published inInvestigative ophthalmology & visual science Vol. 53; no. 7; p. 3913
Main Authors Hiraoka, Takahiro, Kakita, Tetsuhiko, Okamoto, Fumiki, Takahashi, Hideto, Oshika, Tetsuro
Format Journal Article
LanguageEnglish
Published United States 25.06.2012
Subjects
Online AccessGet full text
ISSN1552-5783
1552-5783
DOI10.1167/iovs.11-8453

Cover

Loading…
Abstract Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls. There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups. A total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period. The current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia.
AbstractList Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls. There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups. A total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period. The current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia.
Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls.PURPOSEOur prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those wearing spectacles as controls.There were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups.METHODSThere were 59 subjects enrolled in this study. The OK group comprised 29 subjects who matched the inclusion criteria for OK. The control group comprised 30 subjects who also matched the inclusion criteria for OK, but preferred spectacles for myopia correction. Axial length was measured periodically for 5 years using an IOLMaster device, and the time course of changes was evaluated and compared between the groups.A total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period.RESULTSA total of 43 subjects (22 and 21 in the OK and control groups, respectively) completed the 5-year follow-up examinations. At baseline, the mean age ± SD was 10.04 ± 1.43 and 9.95 ± 1.59 years, the spherical equivalent refractive error was -1.89 ± 0.82 and -1.83 ± 1.06 diopters (D), and the axial length was 24.09 ± 0.77 and 24.22 ± 0.71 mm in the OK and control groups, respectively, with no significant differences between the groups. The increase in axial length during the 5-year study period was 0.99 ± 0.47 and 1.41 ± 0.68 mm for the OK and control groups, respectively, and the difference was statistically significant (P = 0.0236, unpaired t-test). The annual increases in axial length were significantly different between the groups for the first (P = 0.0002), second (P = 0.0476), and third years (P = 0.0385), but not for the fourth (P = 0.0938) and fifth (P = 0.8633) years. There were no severe complications throughout the study period.The current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia.CONCLUSIONSThe current 5-year follow-up study indicated that OK can suppress axial length elongation in childhood myopia.
Author Hiraoka, Takahiro
Kakita, Tetsuhiko
Takahashi, Hideto
Oshika, Tetsuro
Okamoto, Fumiki
Author_xml – sequence: 1
  givenname: Takahiro
  surname: Hiraoka
  fullname: Hiraoka, Takahiro
  organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
– sequence: 2
  givenname: Tetsuhiko
  surname: Kakita
  fullname: Kakita, Tetsuhiko
  organization: Kakita Eye Clinic, Chiba, Japan; and
– sequence: 3
  givenname: Fumiki
  surname: Okamoto
  fullname: Okamoto, Fumiki
  organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
– sequence: 4
  givenname: Hideto
  surname: Takahashi
  fullname: Takahashi, Hideto
  organization: Epidemiology and Biostatistics, School of Medicine, University of Tsukuba, Ibaraki, Japan
– sequence: 5
  givenname: Tetsuro
  surname: Oshika
  fullname: Oshika, Tetsuro
  organization: Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22577080$$D View this record in MEDLINE/PubMed
BookMark eNptkc1PGzEUxK0qVQm0t56RjxzY4o843u0tigJUCsoBcuhp5fU-Zw3OOthOaP77OoSiqurpjUa_eYeZUzTofQ8IfaXkG6VjeWX9LmZVlCPBP6AhFYIVQpZ88Jc-QacxPhLCKGXkEzphTEhJSjJEu7nvV8UDhDWeGQM6YW_wYgeht6su4UVInX-CoJJ3frXHvseTX1Y5PId-lTo8czmuks2-7fG0s67tvG_x3d5vrPqOJ1gUP0EFfO2d8y_FcoPv07bdf0YfjXIRvrzdM7S8nj1Mb4v54ubHdDIvNBcyFZoyro2ojCSt0XI0bsdgSEUq3kjeiLJpsktlxfiogha4ZkLTRlZ0pCjISvAzdHH8uwn-eQsx1WsbNTinevDbWFPCchclGcuMnr-h22YNbb0Jdq3Cvv7TVQYuj4AOPsYA5h2hpD5MUR-myKo-TJFx9g-ubXqtKgVl3f9DvwF1TI0H
CitedBy_id crossref_primary_10_1186_s40662_025_00427_3
crossref_primary_10_1007_s00417_023_06301_z
crossref_primary_10_1111_cxo_12666
crossref_primary_10_3389_fmed_2023_1207328
crossref_primary_10_1111_opo_12834
crossref_primary_10_1016_j_clae_2020_07_001
crossref_primary_10_1016_j_ophtha_2015_11_010
crossref_primary_10_1007_s10792_020_01658_0
crossref_primary_10_1111_opo_13365
crossref_primary_10_1016_j_ajo_2013_04_039
crossref_primary_10_12968_opti_2016_12_148872
crossref_primary_10_1097_ICL_0000000000000476
crossref_primary_10_1097_OPX_0000000000000573
crossref_primary_10_1155_2015_360806
crossref_primary_10_1186_s12967_024_05075_0
crossref_primary_10_1097_OPX_0000000000002197
crossref_primary_10_1007_s00347_019_0873_7
crossref_primary_10_1097_OPX_0000000000002060
crossref_primary_10_1364_JOSAA_450195
crossref_primary_10_52725_aocl_2024_23_2_51
crossref_primary_10_1016_j_clae_2024_102342
crossref_primary_10_1007_s00417_016_3554_0
crossref_primary_10_1016_j_clae_2019_12_001
crossref_primary_10_1111_opo_12027
crossref_primary_10_1016_j_clae_2023_102088
crossref_primary_10_1111_opo_13354
crossref_primary_10_1016_j_clae_2015_07_002
crossref_primary_10_1016_j_clae_2018_10_026
crossref_primary_10_1016_j_clae_2023_102094
crossref_primary_10_1097_ICL_0000000000000460
crossref_primary_10_1097_ICU_0000000000000367
crossref_primary_10_1097_ICL_0000000000000222
crossref_primary_10_1186_s12886_016_0302_5
crossref_primary_10_1186_s40662_020_00214_2
crossref_primary_10_1097_ICL_0000000000000100
crossref_primary_10_1159_000516907
crossref_primary_10_1016_j_clae_2016_02_003
crossref_primary_10_1186_s40662_025_00426_4
crossref_primary_10_1097_ICL_0000000000000207
crossref_primary_10_1016_j_clae_2022_101723
crossref_primary_10_1007_s10384_018_0616_3
crossref_primary_10_3390_children10020402
crossref_primary_10_1186_s12886_022_02635_0
crossref_primary_10_21516_2072_0076_2022_15_1_46_50
crossref_primary_10_12677_ACM_2020_104075
crossref_primary_10_3390_photonics11040332
crossref_primary_10_1167_tvst_11_2_18
crossref_primary_10_1016_j_clae_2020_11_015
crossref_primary_10_1186_s40662_023_00358_x
crossref_primary_10_1097_OPX_0000000000001207
crossref_primary_10_1097_APO_0000000000000256
crossref_primary_10_1186_s12886_020_01477_y
crossref_primary_10_1371_journal_pone_0111766
crossref_primary_10_1097_ICL_0000000000000699
crossref_primary_10_3390_jcm10020336
crossref_primary_10_4103_pajo_pajo_119_21
crossref_primary_10_1111_aos_15746
crossref_primary_10_1111_opo_13213
crossref_primary_10_1186_s13063_021_05197_6
crossref_primary_10_1016_j_ophtha_2014_09_028
crossref_primary_10_1186_s13063_023_07799_8
crossref_primary_10_1111_aos_14658
crossref_primary_10_3389_fmed_2022_1069649
crossref_primary_10_1111_cxo_13067
crossref_primary_10_1016_j_clae_2019_03_003
crossref_primary_10_1007_s10384_023_01012_8
crossref_primary_10_1016_j_optom_2022_03_002
crossref_primary_10_1016_j_clae_2018_10_006
crossref_primary_10_3390_jpm12081316
crossref_primary_10_1080_02713683_2023_2167212
crossref_primary_10_15406_aovs_2016_05_00154
crossref_primary_10_1080_08164622_2021_1896944
crossref_primary_10_1016_j_heliyon_2024_e33341
crossref_primary_10_3390_jcm10040730
crossref_primary_10_1097_APO_0000000000000242
crossref_primary_10_17116_oftalma2017133149_54
crossref_primary_10_1007_s00717_019_0431_3
crossref_primary_10_1097_ICL_0000000000000566
crossref_primary_10_1016_j_clae_2019_11_012
crossref_primary_10_1186_1471_2415_14_141
crossref_primary_10_1111_cxo_12987
crossref_primary_10_1186_s40662_024_00403_3
crossref_primary_10_1111_opo_13208
crossref_primary_10_1080_09273972_2016_1276940
crossref_primary_10_1111_cxo_12862
crossref_primary_10_1155_2017_3703854
crossref_primary_10_1097_OPX_0000000000000808
crossref_primary_10_1136_bjophthalmol_2020_317980
crossref_primary_10_3341_kjo_2016_30_6_434
crossref_primary_10_1167_iovs_62_5_6
crossref_primary_10_1097_OPX_0000000000000259
crossref_primary_10_1097_OPX_0000000000001106
crossref_primary_10_1016_j_clae_2022_101749
crossref_primary_10_1016_j_rfo_2019_10_012
crossref_primary_10_1167_iovs_18_25955
crossref_primary_10_1038_s41598_023_34580_3
crossref_primary_10_1002_14651858_CD013549_pub2
crossref_primary_10_1080_08164622_2022_2113330
crossref_primary_10_12998_wjcc_v9_i30_8985
crossref_primary_10_1097_ICL_0000000000000313
crossref_primary_10_1167_iovs_18_25958
crossref_primary_10_1097_ICL_0000000000000539
crossref_primary_10_1186_s12886_022_02310_4
crossref_primary_10_1111_opo_12460
crossref_primary_10_1016_j_clae_2024_102303
crossref_primary_10_1186_s12886_021_02123_x
crossref_primary_10_1080_08164622_2021_1970480
crossref_primary_10_1186_s12886_022_02480_1
crossref_primary_10_1007_s00417_014_2865_2
crossref_primary_10_1097_OPX_0000000000000916
crossref_primary_10_1016_j_yaoo_2019_04_015
crossref_primary_10_1080_08164622_2024_2447469
crossref_primary_10_4263_jorthoptic_53F104
crossref_primary_10_1016_j_clae_2021_02_003
crossref_primary_10_1364_BOE_486555
crossref_primary_10_1016_j_clae_2020_06_006
crossref_primary_10_3109_02713683_2015_1050743
crossref_primary_10_1097_ICL_0000000000000665
crossref_primary_10_1371_journal_pone_0243416
crossref_primary_10_1097_OPX_0000000000001573
crossref_primary_10_3109_02713683_2015_1009634
crossref_primary_10_1080_15599612_2020_1857889
crossref_primary_10_2147_IJGM_S355181
crossref_primary_10_1038_s41598_023_32700_7
crossref_primary_10_1186_s12886_024_03398_6
crossref_primary_10_1080_02713683_2019_1701685
crossref_primary_10_1097_ICO_0000000000001725
crossref_primary_10_1016_j_clae_2025_102376
crossref_primary_10_1016_j_jfma_2019_02_001
crossref_primary_10_3389_fneur_2022_1006112
crossref_primary_10_1002_14651858_CD013549
crossref_primary_10_1016_j_clae_2015_07_006
crossref_primary_10_3390_antibiotics11020179
crossref_primary_10_1016_j_clae_2025_102381
crossref_primary_10_3390_jcm14030662
crossref_primary_10_1016_j_clae_2014_05_004
crossref_primary_10_1136_bjo_2023_324243
crossref_primary_10_1371_journal_pone_0175913
crossref_primary_10_3341_jkos_2020_61_8_897
crossref_primary_10_1097_OPX_0000000000001127
crossref_primary_10_1136_bjophthalmol_2018_312933
crossref_primary_10_1097_OPX_0000000000000034
crossref_primary_10_1167_tvst_7_6_17
crossref_primary_10_1097_OPX_0000000000000036
crossref_primary_10_1097_OPX_0000000000001367
crossref_primary_10_1167_iovs_18_25977
crossref_primary_10_3389_fbioe_2021_743745
crossref_primary_10_3389_fmed_2023_1130117
crossref_primary_10_1097_ICL_0000000000000516
crossref_primary_10_1080_08164622_2023_2177098
crossref_primary_10_1155_2022_5530162
crossref_primary_10_1111_cxo_12976
crossref_primary_10_12968_opti_2019_12_8057
crossref_primary_10_1016_j_clae_2022_101755
crossref_primary_10_1016_j_exer_2012_11_019
crossref_primary_10_1007_s10384_021_00873_1
crossref_primary_10_1080_08164622_2021_1943318
crossref_primary_10_1111_cxo_12297
crossref_primary_10_1111_opo_12686
crossref_primary_10_3390_vision6020020
crossref_primary_10_1111_ceo_14149
crossref_primary_10_4102_aveh_v79i1_499
crossref_primary_10_1038_s41598_020_71142_3
crossref_primary_10_1097_ICL_0000000000001054
crossref_primary_10_3341_jkos_2024_65_12_786
crossref_primary_10_1097_ICL_0000000000000520
crossref_primary_10_1186_s40662_022_00304_3
crossref_primary_10_1371_journal_pone_0203652
crossref_primary_10_2147_OPTH_S362342
crossref_primary_10_1097_ICL_0000000000000867
crossref_primary_10_1111_cxo_12947
crossref_primary_10_17337_JMBI_2024_26_3_207
crossref_primary_10_1097_ICL_0000000000000629
crossref_primary_10_3109_02713683_2013_841259
crossref_primary_10_1371_journal_pone_0282286
crossref_primary_10_1111_opo_12676
crossref_primary_10_1016_j_jfo_2022_02_003
crossref_primary_10_1186_s12886_022_02693_4
crossref_primary_10_1136_bjo_2023_323764
crossref_primary_10_1136_bjophthalmol_2020_317664
crossref_primary_10_1038_s41467_024_46049_6
crossref_primary_10_1136_bjophthalmol_2021_320318
crossref_primary_10_1155_2017_3279821
crossref_primary_10_1186_s40662_023_00339_0
crossref_primary_10_1038_s41598_020_59157_2
crossref_primary_10_1080_02713683_2020_1820528
crossref_primary_10_1016_j_clae_2017_10_014
crossref_primary_10_1097_OPX_0000000000002119
crossref_primary_10_1002_stem_1984
crossref_primary_10_1080_02713683_2016_1221979
crossref_primary_10_1159_000510779
crossref_primary_10_1371_journal_pmed_1002674
crossref_primary_10_1016_j_clae_2022_101774
crossref_primary_10_1097_ICL_0000000000000977
crossref_primary_10_1111_aos_13866
crossref_primary_10_1007_s40123_023_00755_4
crossref_primary_10_1016_j_clae_2020_05_001
crossref_primary_10_1016_j_clae_2024_102192
crossref_primary_10_1038_eye_2013_255
crossref_primary_10_3389_fped_2022_1057863
crossref_primary_10_1038_eye_2013_256
crossref_primary_10_1097_OPX_0000000000000843
crossref_primary_10_1111_opo_13070
crossref_primary_10_1016_j_clae_2017_10_006
crossref_primary_10_1016_j_clae_2015_06_009
crossref_primary_10_1111_cxo_12839
crossref_primary_10_1186_s12886_021_01865_y
crossref_primary_10_21516_2072_0076_2020_13_3_56_60
crossref_primary_10_1186_s40662_024_00418_w
crossref_primary_10_52725_aocl_2024_23_4_139
crossref_primary_10_1016_j_clae_2023_101841
crossref_primary_10_1155_2020_8067657
crossref_primary_10_1038_s41433_023_02723_5
crossref_primary_10_1097_ICL_0000000000000848
crossref_primary_10_1016_j_ophtha_2014_07_042
crossref_primary_10_1111_opo_12895
crossref_primary_10_1136_bjophthalmol_2020_316475
crossref_primary_10_1007_s00417_019_04555_0
crossref_primary_10_1097_ICL_0000000000000290
crossref_primary_10_1097_ICL_0000000000001142
crossref_primary_10_1007_s10792_024_03175_w
crossref_primary_10_1097_ICL_0000000000000172
crossref_primary_10_12677_HJO_2016_53015
crossref_primary_10_17116_oftalma201913504160
crossref_primary_10_1016_j_biopha_2020_111092
crossref_primary_10_1097_MD_0000000000040139
crossref_primary_10_1167_iovs_17_23707
crossref_primary_10_1016_j_clae_2023_101852
crossref_primary_10_1016_j_clae_2013_09_007
crossref_primary_10_1097_OPX_0000000000000183
crossref_primary_10_1111_aos_16678
crossref_primary_10_1016_j_jfma_2021_05_024
crossref_primary_10_1007_s10384_018_0608_3
crossref_primary_10_1016_j_clae_2024_102167
crossref_primary_10_5318_wjo_v4_i3_63
crossref_primary_10_3928_01913913_20170106_01
crossref_primary_10_1016_j_ophtha_2018_11_026
crossref_primary_10_1186_s12886_022_02294_1
crossref_primary_10_1111_opo_12641
crossref_primary_10_1016_j_clae_2017_09_010
crossref_primary_10_1097_OPX_0000000000000989
crossref_primary_10_1016_j_clae_2014_11_201
crossref_primary_10_1016_j_clae_2024_102172
crossref_primary_10_1136_bmjophth_2023_001499
crossref_primary_10_17116_oftalma2017133543_48
crossref_primary_10_1093_emph_eoy017
crossref_primary_10_1371_journal_pone_0218140
crossref_primary_10_1177_11206721241260456
crossref_primary_10_1097_OPX_0000000000000064
crossref_primary_10_33791_2222_4408_2021_3_47_52
crossref_primary_10_1097_ICL_0000000000001017
crossref_primary_10_1097_OPX_0000000000000066
crossref_primary_10_1016_j_ophtha_2021_04_032
crossref_primary_10_1111_aos_15217
crossref_primary_10_1111_opo_12990
crossref_primary_10_1007_s10384_021_00842_8
crossref_primary_10_1016_j_clae_2023_101862
crossref_primary_10_3109_02713683_2013_790977
crossref_primary_10_1111_opo_13042
crossref_primary_10_1111_cxo_12584
crossref_primary_10_1038_s41598_017_08177_6
crossref_primary_10_1080_09286586_2021_1875010
crossref_primary_10_1038_s41598_019_49041_z
crossref_primary_10_1186_s12886_022_02461_4
crossref_primary_10_1080_08164622_2022_2039555
crossref_primary_10_1136_bjo_2022_321272
crossref_primary_10_3389_fmed_2023_1323851
crossref_primary_10_1097_OPX_0000000000000894
crossref_primary_10_3341_jkos_2018_59_11_1009
crossref_primary_10_5124_jkma_2016_59_1_39
crossref_primary_10_1097_ICL_0000000000001006
crossref_primary_10_1186_s12886_022_02562_0
crossref_primary_10_1016_j_clae_2023_101875
crossref_primary_10_1038_s41598_020_69710_8
crossref_primary_10_1080_02713683_2021_1917619
crossref_primary_10_1111_cxo_12358
crossref_primary_10_1111_aos_14911
crossref_primary_10_1016_j_xops_2024_100563
crossref_primary_10_1038_s41598_020_71710_7
crossref_primary_10_1111_opo_12744
crossref_primary_10_1016_j_clae_2023_102047
crossref_primary_10_1111_opo_12621
crossref_primary_10_3341_jkos_2022_63_4_338
crossref_primary_10_12968_opti_2016_5_127
crossref_primary_10_1016_j_clae_2020_03_018
crossref_primary_10_1097_OPX_0000000000001977
crossref_primary_10_1016_j_heliyon_2023_e14887
crossref_primary_10_1097_OPX_0000000000000762
crossref_primary_10_1097_OPX_0000000000002028
crossref_primary_10_1016_j_clae_2021_101517
crossref_primary_10_1111_aos_16775
crossref_primary_10_1111_opo_13388
crossref_primary_10_1097_ICL_0000000000000801
crossref_primary_10_1111_opo_13029
crossref_primary_10_1016_j_preteyeres_2020_100923
crossref_primary_10_1111_opo_12614
crossref_primary_10_1007_s10792_019_01167_9
crossref_primary_10_1016_j_clae_2024_102256
crossref_primary_10_1016_j_clae_2024_102251
crossref_primary_10_1016_j_clae_2024_102131
crossref_primary_10_1016_j_clae_2020_03_002
crossref_primary_10_1097_ICL_0000000000000252
crossref_primary_10_1155_2023_5553468
crossref_primary_10_1097_ICL_0000000000000493
crossref_primary_10_1097_ICL_0000000000000371
crossref_primary_10_3341_jkos_2019_60_7_620
crossref_primary_10_1097_ICL_0000000000000014
crossref_primary_10_1097_ICL_0b013e318298ee76
crossref_primary_10_1097_OPX_0000000000001520
crossref_primary_10_3928_01913913_20181212_02
crossref_primary_10_1097_ICL_0000000000000499
crossref_primary_10_1111_cxo_12339
crossref_primary_10_1007_s10384_021_00854_4
crossref_primary_10_1186_s12886_021_02148_2
crossref_primary_10_1016_j_clae_2022_101597
crossref_primary_10_1080_02713683_2019_1673438
crossref_primary_10_17116_oftalma2017133389_98
crossref_primary_10_1186_s12886_023_03178_8
crossref_primary_10_1007_s10792_021_01855_5
crossref_primary_10_1016_j_clae_2024_102246
crossref_primary_10_1111_opo_12722
crossref_primary_10_1038_s41433_024_02987_5
crossref_primary_10_1016_j_clae_2016_12_002
crossref_primary_10_1080_07853890_2023_2282745
crossref_primary_10_1136_bmjophth_2018_000204
crossref_primary_10_1186_s12886_017_0639_4
crossref_primary_10_1016_j_clae_2020_08_011
crossref_primary_10_1186_s40662_022_00324_z
crossref_primary_10_1007_s10384_020_00751_2
crossref_primary_10_1111_aos_15662
crossref_primary_10_1177_1120672121998960
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1167/iovs.11-8453
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1552-5783
ExternalDocumentID 22577080
10_1167_iovs_11_8453
Genre Journal Article
Comparative Study
GroupedDBID ---
18M
2WC
34G
39C
5GY
5RE
AAYXX
ACGFO
ACNCT
ADBBV
AENEX
AFOSN
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GROUPED_DOAJ
GX1
N9A
OK1
P2P
RPM
SJN
TR2
TRV
W8F
WH7
WOQ
WOW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c357t-c123cf59f70dfc746d6ef09093b73b58bbfc71792349ede3c25c1b7914a1e7953
ISSN 1552-5783
IngestDate Sun Aug 24 04:15:45 EDT 2025
Thu Apr 03 06:54:23 EDT 2025
Tue Jul 01 02:29:54 EDT 2025
Thu Apr 24 23:06:07 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-c123cf59f70dfc746d6ef09093b73b58bbfc71792349ede3c25c1b7914a1e7953
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 22577080
PQID 1022258067
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1022258067
pubmed_primary_22577080
crossref_primary_10_1167_iovs_11_8453
crossref_citationtrail_10_1167_iovs_11_8453
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-06-25
PublicationDateYYYYMMDD 2012-06-25
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-25
  day: 25
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Investigative ophthalmology & visual science
PublicationTitleAlternate Invest Ophthalmol Vis Sci
PublicationYear 2012
SSID ssj0021120
Score 2.5554008
Snippet Our prospective study was conducted to compare axial length elongation in myopic children receiving long-term overnight orthokeratology (OK) treatment to those...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 3913
SubjectTerms Axial Length, Eye - physiopathology
Child
Eyeglasses
Female
Follow-Up Studies
Humans
Male
Myopia - physiopathology
Myopia - therapy
Orthokeratologic Procedures
Prospective Studies
Time Factors
Title Long-Term Effect of Overnight Orthokeratology on Axial Length Elongation in Childhood Myopia: A 5-Year Follow-Up Study
URI https://www.ncbi.nlm.nih.gov/pubmed/22577080
https://www.proquest.com/docview/1022258067
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiDflJSPBqcrSrJM44YZgqwX2cUml3iLHsUlIG1dtUlh-Bz-YcZy4XdiVFi6R5Thu5fkymbFnvkHoteelJCAu-CaZSDWpNnMYzeB155yQVEgZCZ0ofHIaHE29zzN_Nhj82olaaup0n_-8NK_kf6QKfSBXnSX7D5K1k0IHtEG-cAUJw_VaMj5W1VdH69YuLENbfm3tXO1xj_SJjCo1abLhWdJxxz_0BrkunlLnIzGHx1kf7Mgtx_HiXC0LZrKgfedcM_1IQIv67jTLHTrab30MvCXq2IiRWuZ1zuYL84saVpti3fSJlzsoKlZMla3hGrOS5cVKWdUPNq0xaWNRr5u8KO2ts5IBstrN3UmzKMpiu-9Q6tS03JTgLjJRq93tDB0XEjgm9bnXwD54x9RUt9kXl_R1attwDHfwpDs6mEQmu_Xvj0Ogj6cLtVlD2wm9boYLHNynZ8lkenycxIez-Aa6eQDOh66L8fHTF-vGu4bs0_6pPp0ioG93575o6FzhvbRWTHwX3encD_zeYOkeGojqPrp10gVYPEAbCylsIIWVxBZS-A9IYVXhFlLYQApvIYWLCltIYQOpd5hhAyhsAYVbQD1E08lh_OHI6UpzOJz4tHY4GDxc-pGk40xy6gVZIOQ4GkckpST1wzSFXldzU3qRyAThBz53Uxq5HnMFjXzyCO1VqhJPEA6FJFlGCMxFPBZ4LEwl41mYESk9lkVDNOrXMeEdb70unzJPWv81oIledWgletWH6I0dvTR8LVeMe9WLJAGFqk_JWCVUAwPaLZAQrLghemxkZWeCG5SCj_X0Gk8_Q7e3-H6O9upVI16AAVunL1s8_QYa06Uo
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+effect+of+overnight+orthokeratology+on+axial+length+elongation+in+childhood+myopia%3A+a+5-year+follow-up+study&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Hiraoka%2C+Takahiro&rft.au=Kakita%2C+Tetsuhiko&rft.au=Okamoto%2C+Fumiki&rft.au=Takahashi%2C+Hideto&rft.date=2012-06-25&rft.issn=1552-5783&rft.eissn=1552-5783&rft.volume=53&rft.issue=7&rft.spage=3913&rft_id=info:doi/10.1167%2Fiovs.11-8453&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon